Avantor (AVTR) Receives a Buy from Barclays

Barclays analyst Luke Sergott maintained a Buy rating on Avantor (AVTRResearch Report) on July 29 and set a price target of $33.00. The company’s shares closed last Friday at $29.02, close to its 52-week low of $27.50.

According to TipRanks.com, Sergott is a 4-star analyst with an average return of 6.5% and a 50.7% success rate. Sergott covers the Healthcare sector, focusing on stocks such as Twist Bioscience, IQVIA Holdings, and Thermo Fisher.

Currently, the analyst consensus on Avantor is a Strong Buy with an average price target of $37.50, which is a 31.1% upside from current levels. In a report issued on July 29, Jefferies also maintained a Buy rating on the stock with a $40.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

Based on Avantor’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $1.95 billion and net profit of $190 million. In comparison, last year the company earned revenue of $1.79 billion and had a net profit of $164 million.

Based on the recent corporate insider activity of 86 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of AVTR in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Avantor, Inc. is a provider of mission critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. It sells materials & consumables, equipment & instrumentation and services & specialty procurement. It operates in more than 30 countries and deliver an extensive portfolio of products and services. The company was founded by John Townsend Baker in 1904 and is headquartered in Radnor, PA.

Read More on AVTR:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More